HIGHLIGHTS
- who: Tilman Sauerbruch from the University of Freiburg Medical Center, Germany have published the article: Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?, in the Journal: (JOURNAL) of 09/01/2023
- future: More studies on combination therapy- e_g NSBBs with statins angiotensin II receptor blockers phosphordiesterase-5-inhibitors-drugs that might work against chronic inflammation in cirrhosis or even the combination of NSBBs with a narrow-lumen TIPS are also necessary.
SUMMARY
Beta-blockers, portal hypertension, liver cirrhosis, signaling, carvedilol, adherence Prologue Adrenergic stimulation in liver cirrhosis Around 40 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.